RECEPTOR ALKYLATING AGENTS: NOVEL TOOLS FOR THE STUDY OF RECEPTOR FUNCTION IN THE CENTRAL NERVOUS SYSTEM OF THE RAT
- 1 June 1989
- journal article
- review article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 16 (6) , 545-548
- https://doi.org/10.1111/j.1440-1681.1989.tb01603.x
Abstract
1. The use of alkylating agents to investigate receptor function in the central nervous system is discussed. 2. Examples of strategies which can be used are illustrated by studies with the irreversible dopamine receptor blocker, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). 3. Recent work, in which EEDQ was injected into selected sites of the striatum and receptor loss assessed by quantitative autoradiography, is described to show how this approach can be used to elucidate dopamine receptor function in the striatum.Keywords
This publication has 10 references indexed in Scilit:
- Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in ratsEuropean Journal of Pharmacology, 1988
- Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activityNeuroscience Letters, 1988
- Stimulation of D-1 dopamine receptors facilitates D-2 dopamine receptor recovery after irreversible receptor blockadeNeuropharmacology, 1988
- Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockadeBrain Research, 1987
- Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanismsJournal of Neuroscience, 1987
- Alkylating Derivatives of Oxotremorine Have Irreversible Actions on Muscarinic ReceptorsPublished by Springer Nature ,1986
- Denervation accelerates the reappearance of neostriatal D-2 receptors after irreversible receptor blockadeBrain Research, 1985
- SCH-23390: A selective D1 dopamine antagonist with potent D2 behavioral actionsEuropean Journal of Pharmacology, 1984
- Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinolineLife Sciences, 1983
- The mechanism of irreversible adrenergic blockade by N-carbethoxydihydroquinolines—model studies with typical serine hydrolasesBiochemical Pharmacology, 1969